Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation
氟达拉滨联合减低强度白消安与氟达拉滨联合清髓性白消安治疗接受异基因造血干细胞移植的非霍奇金淋巴瘤患者的疗效比较
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-023-05084-x
Kamijo, Kimimori; Shimomura, Yoshimitsu; Shinohara, Akihito; Mizuno, Shohei; Kanaya, Minoru; Usui, Yoshiaki; Kim, Sung-Won; Ara, Takahide; Mizuno, Ishikazu; Kuriyama, Takuro; Nakazawa, Hideyuki; Matsuoka, Ken-Ichi; Kusumoto, Shigeru; Maseki, Nobuo; Yamaguchi, Masaki; Ashida, Takashi; Onizuka, Makoto; Fukuda, Takahiro; Atsuta, Yoshiko; Kondo, Eisei